证券记录 · 已归档季度
NTRA
Natera, Inc. · Healthcare · Medical - Diagnostics & Research
18被追踪持有人
—Δ持有人
16.29M持有股份
$1.76B报告持仓市值
+0新建仓位
−0清仓
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2024
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 162 | 0 | 104.13M | $28.25B | +5 | −4 |
| Q1 2026 | 164 | +3 | 98.65M | $19.54B | +6 | −4 |
| Q4 2025 | 160 | 0 | 102.31M | $23.44B | +1 | — |
| Q3 2025 | 23 | +1 | 81.70M | $13.15B | +1 | −1 |
| Q2 2025 | 20 | -1 | 57.32M | $9.68B | — | −1 |
| Q1 2025 | 18 | 0 | 31.15M | $4.40B | — | — |
| Q4 2024 | 18 | 0 | 26.97M | $4.27B | — | — |
| Q3 2024 | 17 | -1 | 21.42M | $2.72B | — | −1 |
| Q2 2024 | 18 | — | 16.29M | $1.76B | — | — |
持有人 · Q2 2024
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Citadel Advisors ✦ | 3.05M | — | $330.06M | 0.3% | n/c | 1 | SEC ↗ ×3 |
| 2 | Duquesne Family Office ✦ | 1.97M | — | $213.86M | 7.6% | n/c | 1 | SEC ↗ |
| 3 | Geode Capital Management ✦ (被动) | 1.95M | — | $210.86M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 4 | Millennium Management ✦ | 1.67M | — | $181.30M | 0.2% | n/c | 1 | SEC ↗ ×2 |
| 5 | Norges Bank ✦ (被动) | 1.32M | — | $142.63M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | D. E. Shaw & Co. ✦ | 1.15M | — | $124.03M | 0.2% | n/c | 1 | SEC ↗ |
| 7 | Marshall Wace ✦ | 958.38K | — | $103.78M | 0.1% | n/c | 1 | SEC ↗ ×3 |
| 8 | Wellington Management ✦ | 916.78K | — | $99.28M | 0.0% | n/c | 1 | SEC ↗ ×4 |
| 9 | AQR Capital Management ✦ | 651.52K | — | $70.55M | 0.1% | n/c | 1 | SEC ↗ ×3 |
| 10 | Point72 Asset Management ✦ | 561.94K | — | $60.85M | 0.2% | n/c | 1 | SEC ↗ |
| 11 | T. Rowe Price ✦ | 528.81K | — | $57.27M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 12 | ARK Investment Management ✦ | 415.34K | — | $44.98M | 0.4% | n/c | 1 | SEC ↗ |
| 13 | Capital World Investors ✦ | 396.42K | — | $42.93M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | Two Sigma Investments ✦ | 331.98K | — | $35.95M | 0.1% | n/c | 1 | SEC ↗ |
| 15 | Renaissance Technologies ✦ | 216.50K | — | $23.44M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | Soros Fund Management ✦ | 100.00K | — | $10.83M | 0.3% | n/c | 1 | SEC ↗ |
| 17 | Gotham Asset Management ✦ | 86.42K | — | $9.36M | 0.1% | n/c | 1 | SEC ↗ |
| 18 | Arrowstreet Capital ✦ | 21.53K | — | $2.33M | 0.0% | n/c | 1 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 755 持有人, 120.14M 股份, $20.15B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Oct 01
Chapman Steven Leonard
Officer, Director · 1.27K 股 · $526,144
Sep 23
Sheena Jonathan
Director · 1.94K 股 · $754,090
Sep 23
Sheena Jonathan
Director · 1.34K 股 · $521,332
Sep 23
Sheena Jonathan
Director · 2.85K 股 · $1.10M
Sep 23
Sheena Jonathan
Director · 2.30K 股 · $889,271
Sep 23
Sheena Jonathan
Director · 390 股 · $150,263
Sep 23
Sheena Jonathan
Director · 110 股 · $42,946
Sep 23
Sheena Jonathan
Director · 2.32K 股 · $904,069
Sep 23
Sheena Jonathan
Director · 1.29K 股 · $502,598
Sep 23
Sheena Jonathan
Director · 2.73K 股 · $1.06M
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
Aug 14
SC 13G/A — PRICE T ROWE ASSOCIATES INC /MD/
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2024 ·
方法论 ·
通过API获取此数据